Bugert P, Kovacs G
Department of Urology, Ruprecht Karls University, Heidelberg, Germany.
Am J Pathol. 1996 Dec;149(6):2081-8.
Recent application of molecular cytogenetic techniques has resulted in a new type of genetic classification of renal cell tumors. The key aspect of the novel diagnostic concept is reflected by biologically distinct entities, each characterized by a specific combination of genetic changes. To work out a diagnostic/prognostic approach, we have applied polymorphic microsatellite markers for a quick analysis, based on polymerase chain reaction, of 82 tumor specimens. We compared the results to previously evaluated cytogenetic and histological data. All nonpapillary and chromophobe renal cell carcinomas, which make up approximately 90% of all malignant renal cell tumors, and a subset of renal oncocytomas were correctly diagnosed by detection of loss of heterozygosity at chromosomal sites 1, 2, and 3p. Allelic losses at chromosomal regions 8p, 9p, and 14q are associated with an advanced pathological stage of nonpapillary renal cell carcinomas. A loss of heterozygosity at chromosomes 6, 10, 13, 17, and 21, in addition to those at chromosomes 1 and 2, confirm the diagnosis of chromophobe renal cell tumors. Using this approach, the differential diagnosis of renal cell tumors could be carried out within 1 or 2 days.
分子细胞遗传学技术的近期应用已带来肾细胞肿瘤的新型基因分类。这一新型诊断概念的关键方面体现在生物学上不同的实体,每个实体都以特定的基因变化组合为特征。为制定一种诊断/预后方法,我们应用多态性微卫星标记,基于聚合酶链反应对82个肿瘤标本进行快速分析。我们将结果与先前评估的细胞遗传学和组织学数据进行比较。通过检测染色体位点1、2和3p的杂合性缺失,所有非乳头状和嫌色性肾细胞癌(约占所有恶性肾细胞肿瘤的90%)以及一部分肾嗜酸细胞瘤都得到了正确诊断。染色体区域8p、9p和14q的等位基因缺失与非乳头状肾细胞癌的晚期病理阶段相关。除了染色体1和2上的杂合性缺失外,染色体6、10、13、17和21上的杂合性缺失可确诊嫌色性肾细胞肿瘤。使用这种方法,肾细胞肿瘤的鉴别诊断可在1或2天内完成。